SYDNEY MCBEAN: Open Payments
NPI 1699559849 · LAKE MARY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$321 in 9 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $321
Food & beverage: $321
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $125 |
| Novartis Pharmaceuticals Corporation | 2 | $63 |
| PFIZER INC. | 1 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Genentech USA, Inc. | 1 | $22 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| CSL Behring | 1 | $16 |
Products named: INGREZZA, Rhapsido, PANZYGA, CUVITRU, Xolair, NEFFY, DUPIXENT, Andembry.
Industry payments across FL — which companies pay providers there.
